Control without Shareholding: Board Rights, Vetoes, and Antitrust Risk under Competition Law and Company Law

Why Control Matters beyond Shareholding Thresholds

In Indian regulatory law, control is no longer a concept confined to ownership percentages. Across competition law and company law, regulators increasingly examine who actually influences decision-making rather than who formally holds shares. A person may exercise decisive influence over a company without holding a majority stake, or even without holding any shares at all.

This convergence of approach between the Competition Commission of India and the Registrar of Companies has materially increased regulatory exposure for investors, promoters, directors, and senior management.

Control under the Competition Act, 2002

Under the Competition Act, 2002, the concept of control arises most prominently in the context of combinations under sections 5 and 6, but it also informs analysis of abuse of dominance and coordinated conduct.

CCI has recognised multiple forms of control:

• positive control through affirmative decision-making power
• negative control through veto rights
• material influence through the ability to shape strategic commercial decisions

Material influence is the broadest category and does not require veto rights, board majority, or shareholding thresholds. The potential to influence is sufficient.

Board Representation and Antitrust Risk

Board nomination rights are a key indicator of control. Even a single board seat can trigger antitrust risk where the director:

• participates in strategic decisions
• has access to competitively sensitive information
• represents an investor with overlapping market interests

CCI treats board access as both an influence mechanism and an information conduit.

Example: Minority Investor with Board Seat

An investor holds 12 percent equity and nominates one director. The investor also has exposure to a competing business. Even without veto rights, the board seat may be treated as material influence due to information access and strategic participation.

Veto Rights and Negative Control

Veto rights over strategic matters are among the strongest indicators of control. These include vetoes over:

• business plans and annual budgets
• appointment or removal of key managerial personnel
• capital expenditure
• entry into new markets
• mergers and acquisitions

While often labelled as “protective rights”, CCI evaluates substance over form. If a veto allows an investor to shape commercial strategy, it is likely to be treated as control.

Example: Budget Approval Veto

A shareholder with a 10 percent stake has veto rights over the annual budget. Even if never exercised, the right itself enables influence over strategic direction and may attract merger notification requirements.

Material Influence without Formal Rights

Control can also arise from factual patterns such as:

• advisory roles that management routinely follows
• dependence created by long-term commercial contracts
• historical promoter–investor dynamics
• financing arrangements with operational conditions

CCI frequently infers control from conduct rather than contract wording.

Commercial Agreements as De Facto Control

Control analysis is not limited to shareholders’ agreements. Commercial contracts such as exclusive supply, distribution, franchising, or technology licensing can confer decisive influence where they determine pricing, output, or market access.

Example: Exclusive Distribution Arrangement

A distributor controls pricing, inventory, and customer access of a manufacturer under a long-term exclusive agreement. Even without equity or board rights, the distributor may be treated as exercising de facto control.

Companies Act, 2013 Perspective on Control

While the Companies Act, 2013 does not define “control” in identical terms to competition law, it recognises control through multiple provisions.

Control is relevant for:

• identification of holding, subsidiary, and associate companies
• classification of related parties under section 2(76)
• disclosure of significant influence
• consolidation of financial statements
• determination of promoter or controlling shareholder status

Significant influence under the Companies Act includes participation in financial and operating policy decisions, even without majority control.

Board Rights and Director Duties under Company Law

Board nominees appointed by investors are directors under the Companies Act and owe fiduciary duties to the company, not to the nominating shareholder. This creates inherent tension where board rights are used to exercise control for investor interests.

Directors participating in decisions while representing investor influence may expose themselves to:

• breach of fiduciary duty claims
• scrutiny under oppression and mismanagement provisions
• adverse ROC observations

Example: Investor-Nominated Director Conflict

A nominee director blocks expansion to protect investor interests in another business. Minority shareholders allege breach of duty. ROC scrutiny may follow if governance norms are compromised.

Veto Rights and Shareholder Agreements under Company Law

Extensive veto rights embedded in shareholder agreements often overlap with matters reserved for the board or shareholders under the Companies Act. Where such rights effectively override statutory governance structures, they may:

• undermine board autonomy
• attract shareholder disputes
• complicate enforceability

ROCs increasingly examine whether governance arrangements are consistent with statutory powers under the Act.

ROC Filings and Disclosure Implications

Control-related rights often trigger disclosure obligations under the Companies Act, including:

• disclosure of significant beneficial ownership
• related party disclosures
• filings relating to change in control or management
• board resolutions and explanatory statements

Failure to align contractual control rights with statutory disclosures can lead to penalties and adjudication proceedings.

Example: Undisclosed Control Rights

An investor exercises decisive influence through vetoes and board rights, but the company fails to disclose the relationship as one of significant influence. ROC flags the issue during inspection, leading to penalties for disclosure failure.

Overlap Risks: Competition Law and Company Law

The same rights that trigger antitrust risk often create company law exposure. A structure designed to avoid merger notification may still:

• create related party status
• trigger consolidation requirements
• expose directors to governance liability

Conversely, rights structured to comply with company law may still amount to control for competition purposes.

Practical Structuring and Compliance Considerations

Investors and companies should assess control holistically across regulatory regimes.

Board and veto rights should be narrowly drafted and clearly distinguished between:

• investor protection rights
• strategic or operational control rights

Information rights should be limited, role-based, and supported by real information barriers.

Statutory disclosures under the Companies Act should be aligned with the factual level of influence exercised.

Early coordination between competition law and company law analysis materially reduces regulatory risk.

Enforcement Reality

Regulators increasingly look through form to substance. Control without shareholding is now a recognised enforcement trigger across competition law and company law.

For investors, the greatest risk lies not in equity percentage but in governance rights casually embedded in contracts. For companies, misalignment between contractual control, statutory disclosures, and regulatory filings invites scrutiny from both CCI and ROC.